logo
Twitter
Discord
Email
logo
TruBridge, Inc.

TruBridge, Inc.

NASDAQ•TBRG
CEO: Mr. Christopher L. Fowler
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Listing Date: 2002-05-21
TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.
Contact Information
54 St. Emanuel Street, Mobile, AL, 36602, United States
251-639-8100
www.trubridge.com
Market Cap
$342.96M
P/E (TTM)
-59.3
54.2
Dividend Yield
--
52W High
$32.00
52W Low
$17.71
52W Range
36%
Rank48Top 50.7%
3.7
F-Score
Modified Piotroski Analysis
Based on 9-year fundamentals
Weak • 3.7 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2024

Financial Dashboard

Q3 2025 Data

Revenue

$86.11M+2.71%
4-Quarter Trend

EPS

$0.37-17.78%
4-Quarter Trend

FCF

$13.65M+184.67%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Nine Months Net Income Swing Net income $8.6M for nine months 2025, reversing prior $15.4M loss; operating income $15.9M versus $76K.
Revenue Growth Across Segments Total revenues reached $259.0M, up 2% for nine months; Patient Care revenue increased 3% to $94.1M.
Strong Operating Cash Flow Cash provided by operations totaled $28.1M for nine months 2025, a $6.3M increase over prior period results.
Patient Care EBITDA Surge Patient Care Adjusted EBITDA grew 56% to $21.0M for nine months 2025, driven by installation and SaaS revenue.

Risk Factors

Material Weakness Persists Management concluded material weakness in revenue control design continued through September 30, 2025; remediation underway.
Healthcare Regulatory Uncertainty New OBBBA legislation signed July 2025 creates uncertainty impacting hospital clients' capital allocation and reimbursement funding.
VG Sellers Earnout Dispute Received arbitration request regarding Viewgol earnout provisions; potential litigation exposure currently unestimable liability.
Increased Stock Compensation Costs Net stock-based compensation expense rose to $5.1M for nine months 2025, an increase of $2.2M versus prior year period.

Outlook

Core Growth Strategy Focus Strategy centers on cross-selling Financial Health services into existing Patient Care customer base for long-term growth.
AI Prediction Model Launch Planning first generative AI denials prediction model release to public during first quarter of 2026.
Bookings Reporting Transition Transitioning to Annual Contract Value (ACV) bookings methodology starting January 2025 for better comparability.
Liquidity Position Remains Strong Cash and borrowing capacity provide adequate resources to fund ongoing requirements for next twelve months and beyond.

Peer Comparison

Revenue (TTM)

High Tide Inc.HITI
$394.74M
+9.2%
TruBridge, Inc.TBRG
$349.88M
+3.6%
LifeMD, Inc.LFMD
$252.34M
+40.2%

Gross Margin (Latest Quarter)

LifeMD, Inc.LFMD
111.6%
-8.5pp
Spok Holdings, Inc.SPOK
78.3%
+19.3pp
Definitive Healthcare Corp.DH
76.6%
-1.6pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
CERS$414.62M-21.9-34.2%46.4%
NRC$397.47M24.167.8%59.0%
SLP$393.22M-6.2-37.1%0.5%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-1.8%
Flat Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
100%
Strong Cash Flow

Research & Insights

Next earnings:Mar 9, 2026
|
EPS:$0.41
|
Revenue:-
Reports
All Years
  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 7, 2025|
    Revenue: $86.11M+2.7%
    |
    EPS: $0.37-17.8%
    Miss
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 8, 2025|
    Revenue: $85.73M+1.2%
    |
    EPS: $0.17-158.6%
    Miss
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 9, 2025|
    Revenue: $87.21M+4.8%
    |
    EPS: $0.03-118.1%
    Miss
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Mar 17, 2025|
    Revenue: $342.65M+0.9%
    |
    EPS: $-1.38+56.2%
    Miss
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 12, 2024|
    Revenue: $83.83M+1.4%
    |
    EPS: $0.45-287.5%
    Beat
  • Form 10-Q/A - Q1 2024

    Period End: Mar 31, 2024|Filed: Aug 14, 2024|
    Revenue: $83.25M-3.5%
    |
    EPS: $-0.17-181.0%
    Beat
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 14, 2024|
    Revenue: $84.73M+0.1%
    |
    EPS: $-0.29+45.0%
    Miss
  • Form 10-K/A - FY 2023

    Period End: Dec 31, 2023|Filed: Aug 14, 2024|
    Revenue: $339.44M+3.9%
    |
    EPS: $-3.15-391.7%
    Miss